mRNA 疫苗在实体器官移植受者中的单剂免疫原性。
Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients.
机构信息
Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
出版信息
JAMA. 2021 May 4;325(17):1784-1786. doi: 10.1001/jama.2021.4385.
Abstract
This study quantifies antispike protein antibody responses to first-dose messenger RNA (mRNA) COVID-19 vaccines in solid organ transplant recipients to better understand the immunogenicity of the vaccines in immunocompromised individuals.
摘要
本研究定量分析了实体器官移植受者对信使 RNA（mRNA）COVID-19 疫苗首剂的抗刺突蛋白抗体反应，以更好地了解疫苗在免疫功能低下个体中的免疫原性。
相似文献
1
Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients.
JAMA. 2021 May 4;325(17):1784-1786. doi: 10.1001/jama.2021.4385.
2
SARS-CoV-2 Messenger RNA Vaccine Immunogenicity in Solid Organ Transplant Recipients With Prior COVID-19.
Transplantation. 2021 Nov 1;105(11):e270-e271. doi: 10.1097/TP.0000000000003900.
3
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients.
JAMA. 2021 Jun 1;325(21):2204-2206. doi: 10.1001/jama.2021.7489.
4
Poor Humoral Response in Solid Organ Transplant Recipients Following Complete mRNA SARS-CoV-2 Vaccination.
Clin Chem. 2021 Dec 30;68(1):251-253. doi: 10.1093/clinchem/hvab149.
5
Differences in Antibody Responses Between an Inactivated SARS-CoV-2 Vaccine and the BNT162b2 mRNA Vaccine in Solid-Organ Transplant Recipients.
Exp Clin Transplant. 2021 Dec;19(12):1334-1340. doi: 10.6002/ect.2021.0402.
6
Antibody Response to the Janssen COVID-19 Vaccine in Solid Organ Transplant Recipients.
Transplantation. 2021 Aug 1;105(8):e82-e83. doi: 10.1097/TP.0000000000003850.
7
Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial.
JAMA Intern Med. 2022 Feb 1;182(2):165-171. doi: 10.1001/jamainternmed.2021.7372.
8
Improved immunogenicity against SARS-CoV-2 in a solid-organ transplant recipient by switching vaccines.
Clin Microbiol Infect. 2021 Oct;27(10):1529-1530. doi: 10.1016/j.cmi.2021.06.022. Epub 2021 Jun 27.
9
SARS-CoV-2 anti-spike IgG antibodies are present in all liver transplant recipients after fifth vaccine dose.
J Hepatol. 2024 Jun;80(6):e284-e286. doi: 10.1016/j.jhep.2023.12.008. Epub 2023 Dec 16.
10
Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients.
N Engl J Med. 2021 Aug 12;385(7):661-662. doi: 10.1056/NEJMc2108861. Epub 2021 Jun 23.
引用本文的文献
1
Outcomes of SARS-CoV-2 infection in patients under treatment with pharmacological immunosuppression. A Swiss cohort study.
Arch Med Sci. 2022 Aug 3;21(3):845-851. doi: 10.5114/aoms/152340. eCollection 2025.
2
Post-COVID-19 cardiovascular disease risk in kidney transplant recipients.
Am J Transplant. 2025 Jul 15. doi: 10.1016/j.ajt.2025.07.2462.
3
Optimized tacrolimus dosing strategy in kidney transplant recipients receiving nirmatrelvir-ritonavir for COVID-19.
PLoS One. 2025 May 30;20(5):e0309875. doi: 10.1371/journal.pone.0309875. eCollection 2025.
4
Antibody Response to Covishield and Covaxin in Kidney Transplant Recipients.
Indian J Nephrol. 2025 Mar-Apr;35(2):277-282. doi: 10.25259/ijn_549_23. Epub 2024 Aug 1.
5
A third COVID-19 vaccine dose in kidney transplant recipients induces antibody response to vaccine and Omicron variants but shows limited Ig subclass switching.
Microbiol Spectr. 2025 Mar 4;13(3):e0219024. doi: 10.1128/spectrum.02190-24. Epub 2025 Jan 31.
6
Adaptive clinical trial of AZD7442 and SARS-CoV-2 vaccination in immunosuppressed patients highly vulnerable to infection with SARS-CoV-2 virus (RAPID-PROTECTION): protocol for a multicentre, interventional open-label, randomised controlled trial.
BMJ Open. 2025 Jan 20;15(1):e084345. doi: 10.1136/bmjopen-2024-084345.
7
Antibody Response to SARS-CoV-2 Vaccines in Transplant Recipients and Hemodialysis Patients: Data from the Dominican Republic.
Vaccines (Basel). 2024 Nov 23;12(12):1312. doi: 10.3390/vaccines12121312.
8
Impact of Immunosuppressants and Vaccination on COVID-19 Outcomes in Autoimmune Patients and Solid Organ Transplant Recipients: A Nationwide Propensity Score-Matched Study.
Vaccines (Basel). 2024 Oct 18;12(10):1190. doi: 10.3390/vaccines12101190.
9
Role of SARS-CoV-2-specific memory B cells promoting immune protection after booster vaccination in solid organ transplantation.
Front Immunol. 2024 Oct 8;15:1463769. doi: 10.3389/fimmu.2024.1463769. eCollection 2024.
10
Antibody Response to BNT162b2 Vaccine in Immune Modifiers-Treated Psoriatic Patients.
J Psoriasis Psoriatic Arthritis. 2022 Jan;7(1):24-28. doi: 10.1177/24755303211056059. Epub 2021 Nov 12.
Zotero 插件